David R. McAvoy - 17 May 2021 Form 4 Insider Report for Brickell Biotech, Inc.

Role: General Counsel and CCO
Signature: /s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed)
Issuer symbol: N/A
Transactions as of: 17 May 2021
Net transactions value: +$21,282
Form type: 4
Filing time: 19 May 2021, 17:02:26 UTC
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FRTX	Common Stock	Purchase	$14,898	+18,622	+20%	$0.8000	110,755	17 May 2021	Direct	F1
transaction	FRTX	Common Stock	Purchase	$6,384	+7,980	+133%	$0.8000	13,980	17 May 2021	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the purchase of 18,622 shares in multiple transactions, ranging in price from $0.7942 to $0.8097 per share, resulting in a weighted average purchase price of $0.806. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.